FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13760911000001108: Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
49037601000001111 Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
49037701000001118 Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Is a Product containing precisely oxybutynin hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Has active ingredient Oxybutynin hydrochloride false Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Has specific active ingredient Oxybutynin hydrochloride true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) 84 tablet Is pack of False Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) 84 tablet Has AMP True Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) 56 tablet Has AMP True Oxybutynin 5mg tablets (Tillomed Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start